 |
Diseases |  |
Trials |
|
Trials |  |
News |  |
- || NasoShield (anthrax intranasal vaccine) / Altimmune
Trial completion: NasoShield in Healthy Adults to Study Safety and Immunogenicity (clinicaltrials.gov) - May 13, 2021
P1, N=42, Completed, Sponsor: Altimmune, Inc.
Active, not recruiting --> Completed
- | NasoShield (anthrax intranasal vaccine) / Altimmune
Trial primary completion date: NasoShield in Healthy Adults to Study Safety and Immunogenicity (clinicaltrials.gov) - Jan 18, 2021
P1, N=42, Active, not recruiting, Sponsor: Altimmune, Inc.
Active, not recruiting --> Completed Trial primary completion date: Nov 2020 --> Mar 2021
- || NasoShield (anthrax intranasal vaccine) / Altimmune
Enrollment closed: NasoShield in Healthy Adults to Study Safety and Immunogenicity (clinicaltrials.gov) - Sep 29, 2020
P1, N=42, Active, not recruiting, Sponsor: Altimmune, Inc.
Trial primary completion date: Nov 2020 --> Mar 2021 Recruiting --> Active, not recruiting
- || NasoShield (anthrax intranasal vaccine) / Altimmune
Enrollment open: NasoShield in Healthy Adults to Study Safety and Immunogenicity (clinicaltrials.gov) - Jun 18, 2020
P1, N=42, Recruiting, Sponsor: Altimmune, Inc.
Recruiting --> Active, not recruiting Not yet recruiting --> Recruiting
- || NasoShield (anthrax intranasal vaccine) / Altimmune
New P1 trial: NasoShield in Healthy Adults to Study Safety and Immunogenicity (clinicaltrials.gov) - Jun 3, 2020
P1, N=42, Not yet recruiting, Sponsor: Altimmune, Inc.
- | NasoShield (anthrax intranasal vaccine) / Altimmune
Enrollment closed, Trial primary completion date: NasoShield Study of Safety and Immunogenicity (clinicaltrials.gov) - Nov 29, 2018
P1, N=145, Active, not recruiting, Sponsor: Altimmune, Inc.
Not yet recruiting --> Recruiting Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2018 --> Aug 2018
- | NasoShield (anthrax intranasal vaccine) / Altimmune
Trial completion date: NasoShield Study of Safety and Immunogenicity (clinicaltrials.gov) - Mar 19, 2018
P1, N=145, Recruiting, Sponsor: Altimmune, Inc.
Recruiting --> Active, not recruiting | Trial primary completion date: Jun 2018 --> Aug 2018 Trial completion date: Mar 2019 --> Aug 2019
- ||| NasoShield (anthrax intranasal vaccine) / Altimmune
Enrollment open: NasoShield Study of Safety and Immunogenicity (clinicaltrials.gov) - Jan 24, 2018
P1, N=145, Recruiting, Sponsor: Altimmune, Inc.
Trial completion date: Mar 2019 --> Aug 2019 Not yet recruiting --> Recruiting
- ||| NasoShield (anthrax intranasal vaccine) / Altimmune
New P1 trial: NasoShield Study of Safety and Immunogenicity (clinicaltrials.gov) - Nov 24, 2017
P1, N=145, Not yet recruiting, Sponsor: Altimmune, Inc.